| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $84.5M | +38.7% |
| Cost of Revenue | $54.2M | +12.3% |
| Gross Profit | $30.2M | +140.0% |
| R&D Expense | $11.6M | +130.3% |
| SG&A Expense | $12.9M | -18.6% |
| Operating Income | $3.9M | +137.8% |
| Pre-tax Income | $2.5M | +121.4% |
| Income Tax | $632K | +126.3% |
| Net Income | $1.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | -51.9% |
| Current Assets | $31.2M | -44.8% |
| Total Assets | $62.2M | -31.5% |
| Current Liabilities | $36.2M | -49.3% |
| Long-term Debt | $5.7M | -53.2% |
| Total Liabilities | $58.0M | -34.1% |
| Stockholders' Equity | $9.7M | +16.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -436.0% |
| Financing Cash Flow | -$6.5M | -88.5% |
| +120.2% |
| EPS (Basic) | $0.05 | +120.0% |
| EPS (Diluted) | $0.05 | +120.0% |